Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mario Setaro
Observed name:
M. Setaro
Institutions:
CEINGE Biotecnologie Avanzate Franco Salvatore (Italy),
University of Naples Federico II
Observed institutions:
CEINGE Biotecnologie Avanzate Franco Salvatore (Italy),
University of Naples Federico II
ORCID:
0000-0002-7984-8009
Observed ORCID:
0000-0002-7984-8009
OpenAlex ID:
A5022980903
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?
2021
·
Carmela Nardelli
, Ivan Gentile
, et al.
·
Frontiers in Cellular and Infection Microbiology
·
82
PDF
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial
2022
·
E.D. Capoluongo
, B. Pellegrino
, et al.
·
ESMO Open
·
48
PDF
16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal Cancer
2021
·
Carmela Nardelli
, Ilaria Granata
, et al.
·
International Journal of Molecular Sciences
·
43
PDF
Nasal Microbiome in COVID-19: A Potential Role of Corynebacterium in Anosmia
2022
·
Carmela Nardelli
, Giovanni Luca Scaglione
, et al.
·
Current Microbiology
·
19
PDF
Case Report: Detection of a Novel Germline PALB2 Deletion in a Young Woman With Hereditary Breast Cancer: When the Patient's Phenotype History Doesn't Lie
2021
·
Carmine De Angelis
, Carmela Nardelli
, et al.
·
Frontiers in Oncology
·
7
PDF
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma
2021
·
Ettore Capoluongo
, Carmela Nardelli
, et al.
·
Frontiers in Oncology
·
2
PDF
Show more works
View as search
Works count:
6
Citation count:
201
H-index:
5
I10-index:
4
Year
Topic
Type